Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Rajiv Mundayat,Michelle Stewart,Jose Alvir,Sarah Short,Moh-Lim Ong,Denis Keohane,Denise Rill,Marla B. Sultan

Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

2018

Rajiv Mundayat
Michelle Stewart
Jose Alvir
Sarah Short
Moh-Lim Ong
Denis Keohane
Denise Rill
Marla B. Sultan

Introduction The effectiveness of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy (TTR-FAP) was evaluated using data from the Transthyretin Amyloidosis Outcomes Survey (THAOS) registry.

Keywords:

Physical therapy
Transthyretin
Medicine
Disease
Amyloidosis
Amyloid polyneuropathy
Internal medicine
Tafamidis
Clinical trial
Propensity score matching
Hazard ratio
Body mass index
Neurology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations